Mainstream

Castle Biosciences raises 2025 revenue guidance to $310M–$320M following strong Q2 execution and test volume growth

Castle Biosciences raises 2025 revenue guidance to $310M–$320M following strong Q2 execution and test volume growth

Post ContentcstlRead More

You might also be interested in reading What comes after spot Ether ETF approvals? Execs weigh in.

August 5, 2025
In Mainstream